ASCVD |
atherosclerotic cardiovascular disease |
AU |
Agatston units |
BMI |
body mass index |
BP |
blood pressure |
CHD |
coronary heart disease |
CKD |
chronic kidney disease |
CVD |
cardiovascular disease |
DASH |
Dietary Approaches to Stop Hypertension |
DBP |
diastolic blood pressure |
DM |
diabetes mellitus |
ENDS |
electronic nicotine delivery systems |
FDA |
US Food and Drug Administration |
GLP-1R |
glucagon-like peptide-1 receptor |
HbA1c |
hemoglobin A1c |
HDL-C |
high-density lipoprotein cholesterol |
HbA1c |
hemoglobin A1c |
LDL-C |
low-density lipoprotein cholesterol |
MI |
myocardial infarction |
PCE |
pooled cohort equations |
RCT |
randomized controlled trial |
SBP |
systolic blood pressure |
SGLT-2 |
sodium-glucose cotransporter 2 |
T2DM |
type 2 diabetes mellitus |
USPSTF |
US Preventive Services Task Force |